ARCHIVES

Drug pricing: Amgen’s “bundling” violates antitrust laws, J&J claims in suit.

This article is from The Cancer Letter archive.

Vol. 31 No. 37 | October 14, 2005

Download PDF Visit The Full Archive

Related Articles

For R01s, 195 or P01s Center Funds Up By $600,000

May 22, 1981

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

January 25, 2002

Joint NCI/FDA Program approved; ‘May Solve Our Differences’

December 15, 1989

Rising Obesity May Result In Higher Cancer Incidence

August 27, 2010

Scientists should lobby Congress to support the project, Broad Institute Director Eric Lander says.

March 18, 2005

In Brief: St. Jude, Yale to Get Bristol-Myers Grants; Five Named for New Young Scientists Awards

May 6, 1988